Pharmacoeconomics: from theory to practice
In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Boca Raton ; London ; New York
CRC Press, Taylor & Francis Group
2021
|
Ausgabe: | Second edition |
Schlagworte: | |
Online-Zugang: | UBT01 Volltext |
Zusammenfassung: | In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter |
Beschreibung: | 1 Online-Ressource (xiv, 319 Seiten) Illustrationen |
ISBN: | 9780429491368 |
DOI: | 10.1201/9780429491368 |
Internformat
MARC
LEADER | 00000nmm a2200000 c 4500 | ||
---|---|---|---|
001 | BV046940248 | ||
003 | DE-604 | ||
005 | 20220322 | ||
007 | cr|uuu---uuuuu | ||
008 | 201014s2021 |||| o||u| ||||||eng d | ||
020 | |a 9780429491368 |c Online |9 978-0-429-49136-8 | ||
024 | 7 | |a 10.1201/9780429491368 |2 doi | |
035 | |a (OCoLC)1220892634 | ||
035 | |a (DE-599)BVBBV046940248 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-703 | ||
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
245 | 1 | 0 | |a Pharmacoeconomics |b from theory to practice |c edited by Renée J.G. Arnold, PharmD, RPh |
250 | |a Second edition | ||
264 | 1 | |a Boca Raton ; London ; New York |b CRC Press, Taylor & Francis Group |c 2021 | |
300 | |a 1 Online-Ressource (xiv, 319 Seiten) |b Illustrationen | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | 3 | |a In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter | |
650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
653 | 0 | |a Drugs / Cost effectiveness | |
653 | 0 | |a Pharmacy / Economic aspects | |
653 | 0 | |a Decision making | |
653 | 0 | |a MEDICAL / Pharmacology | |
653 | 6 | |a Electronic books | |
689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 0 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Arnold, Renée J. G. |0 (DE-588)139675620 |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Festeinband |z 978-1-138-58983-4 |
856 | 4 | 0 | |u https://doi.org/10.1201/9780429491368 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ebook |a ZDB-7-TFC | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-032348986 | ||
966 | e | |u https://doi.org/10.1201/9780429491368 |l UBT01 |p ZDB-7-TFC |q UBT_Einzelkauf_2020 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804181841984356353 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Arnold, Renée J. G. |
author2_role | edt |
author2_variant | r j g a rjg rjga |
author_GND | (DE-588)139675620 |
author_facet | Arnold, Renée J. G. |
building | Verbundindex |
bvnumber | BV046940248 |
classification_rvk | QR 525 |
collection | ebook ZDB-7-TFC |
ctrlnum | (OCoLC)1220892634 (DE-599)BVBBV046940248 |
discipline | Wirtschaftswissenschaften |
discipline_str_mv | Wirtschaftswissenschaften |
doi_str_mv | 10.1201/9780429491368 |
edition | Second edition |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03156nmm a2200469 c 4500</leader><controlfield tag="001">BV046940248</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220322 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201014s2021 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780429491368</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-429-49136-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1201/9780429491368</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220892634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046940248</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics</subfield><subfield code="b">from theory to practice</subfield><subfield code="c">edited by Renée J.G. Arnold, PharmD, RPh</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton ; London ; New York</subfield><subfield code="b">CRC Press, Taylor & Francis Group</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiv, 319 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drugs / Cost effectiveness</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy / Economic aspects</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Decision making</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">MEDICAL / Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnold, Renée J. G.</subfield><subfield code="0">(DE-588)139675620</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Festeinband</subfield><subfield code="z">978-1-138-58983-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1201/9780429491368</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield><subfield code="a">ZDB-7-TFC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032348986</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1201/9780429491368</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-7-TFC</subfield><subfield code="q">UBT_Einzelkauf_2020</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046940248 |
illustrated | Not Illustrated |
index_date | 2024-07-03T15:37:50Z |
indexdate | 2024-07-10T08:58:04Z |
institution | BVB |
isbn | 9780429491368 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032348986 |
oclc_num | 1220892634 |
open_access_boolean | |
owner | DE-703 |
owner_facet | DE-703 |
physical | 1 Online-Ressource (xiv, 319 Seiten) Illustrationen |
psigel | ebook ZDB-7-TFC ZDB-7-TFC UBT_Einzelkauf_2020 |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
publisher | CRC Press, Taylor & Francis Group |
record_format | marc |
spelling | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh Second edition Boca Raton ; London ; New York CRC Press, Taylor & Francis Group 2021 1 Online-Ressource (xiv, 319 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier In this era of finite budgets, healthcare rationing, medication shortages, and the global aging and burgeoning of populations, numerous stakeholders in the healthcare arena must understand the basic principles of pharmacoeconomics and how these may be correctly applied to facilitate drug development, rationing, patient segmentation, disease management, and pricing model development. Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to more efficiently and rationally leverage these healthcare resources, not by restricting access to necessary services, but by using them more efficiently. This updated volume arms decision makers with the tools they need to make wise choices in an area where the stakes are extremely highthe health of the global population. Key Features: Introduces the major concepts and principles of Pharmacoeconomics Gives updated information about pharmacoeconomic models, value-based pricing, novel modelling methodologies and international utilization of these modalities in government, the pharmaceutical industry, and health care settings Demonstrates the full range of ethical and moral issues, as well as overall public health and commercial concerns that are often involved in decisions entailing pharmacoeconomic issues Presents both theory and methodology discussions, including real-world examples, in each chapter Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Drugs / Cost effectiveness Pharmacy / Economic aspects Decision making MEDICAL / Pharmacology Electronic books Pharmakotherapie (DE-588)4076066-2 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Arnold, Renée J. G. (DE-588)139675620 edt Erscheint auch als Druck-Ausgabe, Festeinband 978-1-138-58983-4 https://doi.org/10.1201/9780429491368 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Pharmacoeconomics from theory to practice Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
subject_GND | (DE-588)4032589-1 (DE-588)4076066-2 |
title | Pharmacoeconomics from theory to practice |
title_auth | Pharmacoeconomics from theory to practice |
title_exact_search | Pharmacoeconomics from theory to practice |
title_exact_search_txtP | Pharmacoeconomics from theory to practice |
title_full | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
title_fullStr | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
title_full_unstemmed | Pharmacoeconomics from theory to practice edited by Renée J.G. Arnold, PharmD, RPh |
title_short | Pharmacoeconomics |
title_sort | pharmacoeconomics from theory to practice |
title_sub | from theory to practice |
topic | Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
topic_facet | Kosten-Nutzen-Analyse Pharmakotherapie |
url | https://doi.org/10.1201/9780429491368 |
work_keys_str_mv | AT arnoldreneejg pharmacoeconomicsfromtheorytopractice |